AIMA Releases First 50mL Bodyfill Vial: One-Stop OEM/ODM Customization Opens Up a New Track for Non-Surgical Shaping

[May 2026] Along with the explosive growth of the global body aesthetics market, medical aesthetic clinics and patients are facing an increasingly urgent demand for non-surgical, safe, and highly efficient body shaping solutions. In response, AIMA has officially launched its breakthrough innovation—the 50mL Bodyfill Vial. This marks not only another major milestone in AIMA’s hyaluronic acid technology but also a high-performance solution tailored specifically for soft tissue augmentation in breasts and buttocks.

This body filler features a high concentration (25mg/mL) of cross-linked sodium hyaluronate gel, innovatively integrated with 0.3% lidocaine. This specific formulation ensures exceptional lifting support and structural integrity while significantly enhancing patient comfort during the injection process.

Compared to traditional small-volume facial fillers, this product represents a massive leap forward: the initial injection volume can reach up to 50mL per breast and 100mL per buttock cheek. It allows patients to rapidly achieve perfect body contours without undergoing the lengthy recovery periods and high risks associated with traditional surgery. The clinical results last between 12 and 24 months, and a shelf life of up to 3 years provides clinics with ultimate inventory turnover flexibility.

As a leading global medical aesthetic supply chain partner, AIMA fully opens up global private label (OEM/ODM) cooperation for this 50mL body filler. We provide a one-stop, flexible customization service covering unique formulation fine-tuning, packaging visual design, and regulatory compliance registration. This empowers global aesthetic brands and chain clinics to precisely capture the highly profitable blue ocean of body aesthetics and rapidly build up their own brand barriers.